Negative autoregulation of RANKL and c-Src signaling in osteoclasts (Q28307600)

Journal of Bone and Mineral Metabolism

Europe PubMed Central

title

Negative autoregulation of RANKL and c-Src signaling in osteoclasts (English)

0 references

author name string

Keiichiro Yogo

series ordinal

1

0 references

Norihiro Ishida-Kitagawa

series ordinal

2

0 references

Tatsuo Takeya

series ordinal

3

0 references

language of work or name

English

0 references

publication date

2007

0 references

published in

0 references

volume

25

0 references

issue

4

0 references

page(s)

205-10

0 references

cites work

NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation

1 reference

https://api.crossref.org/works/10.1007%2FS00774-007-0751-2

Deficiency of SHP-1 protein-tyrosine phosphatase activity results in heightened osteoclast function and decreased bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-007-0751-2

Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-007-0751-2

Receptor Activator of NF-κB Ligand Stimulates Recruitment of SHP-1 to the Complex Containing TNFR-Associated Factor 6 That Regulates Osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-007-0751-2

The expanding role of PI3-kinase in bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-007-0751-2

Podosome and sealing zone: specificity of the osteoclast model

21 January 2018

1 reference

12 December 2020

Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene

1 reference

12 December 2020

CCR1 acts downstream of NFAT2 in osteoclastogenesis and enhances cell migration

1 reference

12 December 2020

Phosphatidylinositol 3,4,5-trisphosphate directs association of Src homology 2-containing signaling proteins with gelsolin

1 reference

12 December 2020

Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts

1 reference

12 December 2020

Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos

1 reference

12 December 2020

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

1 reference

12 December 2020

c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption.

1 reference

12 December 2020

Type I interferons in host defense

1 reference

12 December 2020

The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor

1 reference

12 December 2020

RANKL-RANK signaling in osteoclastogenesis and bone disease

1 reference

12 December 2020

Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis

1 reference

12 December 2020

Tyrosine phosphorylation of p130Cas is involved in actin organization in osteoclasts.

1 reference

12 December 2020

Signal transduction pathways regulating osteoclast differentiation and function

1 reference

12 December 2020

Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1

1 reference

12 December 2020

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

12 December 2020

Calcitonin Plays a Critical Role in Regulating Skeletal Mineral Metabolism during Lactation

1 reference

12 December 2020

Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice

1 reference

12 December 2020

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

1 reference

12 December 2020

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ

1 reference

12 December 2020

TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling

1 reference

12 December 2020

The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase

1 reference

12 December 2020

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

1 reference

12 December 2020

Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis

1 reference

12 December 2020

c-Src is required for stimulation of gelsolin-associated phosphatidylinositol 3-kinase

1 reference

12 December 2020

Podosomes as smart regulators of cellular adhesion.

1 reference

12 December 2020

Src homology 2 (SH2)-containing 5'-inositol phosphatase localizes to podosomes, and the SH2 domain is implicated in the attenuation of bone resorption in osteoclasts

1 reference

12 December 2020

Cellular functions regulated by Src family kinases

1 reference

12 December 2020

Phosphatidylinositol 3-kinase association with the osteoclast cytoskeleton, and its involvement in osteoclast attachment and spreading

1 reference

12 December 2020

Osteoclast signalling pathways

1 reference

12 December 2020

Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation

1 reference

12 December 2020

Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts.

1 reference

12 December 2020

Abnormal localisation and hyperclustering of (alpha)(V)(beta)(3) integrins and associated proteins in Src-deficient or tyrphostin A9-treated osteoclasts

1 reference

12 December 2020

IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL

1 reference

12 December 2020

Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility

1 reference

12 December 2020

Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase

1 reference

12 December 2020

Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator

1 reference

12 December 2020

Interferon-alpha and -beta differentially regulate osteoclastogenesis: role of differential induction of chemokine CXCL11 expression.

1 reference

12 December 2020

Src kinase activity is essential for osteoclast function

1 reference

12 December 2020

RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism

1 reference

12 December 2020

Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice

1 reference

12 December 2020

Induction of mouse c-src in RAW264 cells is dependent on AP-1 and NF-kappaB and important for progression to multinucleated cell formation

1 reference

12 December 2020

Physical and functional association of c-Src and adhesion and degranulation promoting adaptor protein (ADAP) in osteoclastogenesis in vitro

1 reference

12 December 2020

RANKL stimulates inducible nitric-oxide synthase expression and nitric oxide production in developing osteoclasts. An autocrine negative feedback mechanism triggered by RANKL-induced interferon-beta via NF-kappaB that restrains osteoclastogenesis an

1 reference

12 December 2020

Genetic regulation of osteoclast development and function

1 reference

12 December 2020

Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro

1 reference

12 December 2020

Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice

1 reference

12 December 2020

p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity

1 reference

12 December 2020

PTEN regulates RANKL- and osteopontin-stimulated signal transduction during osteoclast differentiation and cell motility

1 reference

12 December 2020

PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase

1 reference

12 December 2020

The role(s) of Src kinase and Cbl proteins in the regulation of osteoclast differentiation and function

1 reference

12 December 2020

TSH Is a Negative Regulator of Skeletal Remodeling

1 reference

12 December 2020

SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts

1 reference

12 December 2020

RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β

1 reference

12 December 2020

The tyrosine phosphatase SHP-1 is a negative regulator of osteoclastogenesis and osteoclast resorbing activity: increased resorption and osteopenia in me(v)/me(v) mutant mice

1 reference

12 December 2020

Regulation of receptor activator of NF-kappa B ligand-induced osteoclastogenesis by endogenous interferon-beta (INF-beta ) and suppressors of cytokine signaling (SOCS). The possible counteracting role of SOCSs- in IFN-beta-inhibited osteoclast forma

1 reference

12 December 2020

Autoamplification of NFATc1 expression determines its essential role in bone homeostasis

1 reference

12 December 2020